期刊
NATURE REVIEWS CANCER
卷 2, 期 10, 页码 740-749出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc906
关键词
-
类别
A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs. That they are the most direct and hopeful targets for treating cancer is proposed, and this is supported by the fact that there are many more human oncogenes in signalling pathways than there are oncogenic transcription factors. But how could specific transcription-factor activity be inhibited?.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据